John Schussler

3.8k total citations
35 papers, 2.0k citations indexed

About

John Schussler is a scholar working on Epidemiology, Surgery and Microbiology. According to data from OpenAlex, John Schussler has authored 35 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 15 papers in Surgery and 6 papers in Microbiology. Recurrent topics in John Schussler's work include Cervical Cancer and HPV Research (33 papers), Hepatitis B Virus Studies (17 papers) and Genital Health and Disease (14 papers). John Schussler is often cited by papers focused on Cervical Cancer and HPV Research (33 papers), Hepatitis B Virus Studies (17 papers) and Genital Health and Disease (14 papers). John Schussler collaborates with scholars based in United States, Costa Rica and France. John Schussler's co-authors include Mark Schiffman, Philip E. Castle, Allan Hildesheim, Sholom Wacholder, Rolando Herrero, Mark E. Sherman, Robert D. Burk, Attila T. Lörincz, M. Concepción Bratti and Diane Solomon and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

John Schussler

30 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Schussler United States	19	1.9k	794	327	301	289	35	2.0k
Joseph Monsonégo France	22	2.2k 1.2×	1.0k 1.3×	468 1.4×	348 1.2×	326 1.1×	70	2.5k
Paulo Naud Brazil	20	2.2k 1.2×	812 1.0×	456 1.4×	281 0.9×	248 0.9×	49	2.7k
Jessica Keys United States	6	1.2k 0.7×	626 0.8×	171 0.5×	236 0.8×	196 0.7×	11	1.5k
Frances B. Alvarez United States	8	1.8k 1.0×	648 0.8×	299 0.9×	176 0.6×	197 0.7×	8	2.1k
Sara Tous Spain	19	1.2k 0.6×	707 0.9×	240 0.7×	159 0.5×	112 0.4×	47	1.5k
PJF Snijders Netherlands	9	1.6k 0.8×	750 0.9×	291 0.9×	378 1.3×	279 1.0×	9	1.8k
Allan Hildesheim United States	19	1.9k 1.0×	758 1.0×	432 1.3×	284 0.9×	254 0.9×	25	2.3k
Sukhon Sukvirach France	8	1.4k 0.8×	740 0.9×	254 0.8×	122 0.4×	317 1.1×	10	1.5k
Constance Mao United States	17	1.2k 0.7×	536 0.7×	314 1.0×	176 0.6×	159 0.6×	25	1.4k
Concepción Bratti United States	17	1.6k 0.9×	787 1.0×	286 0.9×	291 1.0×	331 1.1×	26	1.9k

Countries citing papers authored by John Schussler

Since Specialization

Citations

This map shows the geographic impact of John Schussler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Schussler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Schussler more than expected).

Fields of papers citing papers by John Schussler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Schussler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Schussler. The network helps show where John Schussler may publish in the future.

Co-authorship network of co-authors of John Schussler

This figure shows the co-authorship network connecting the top 25 collaborators of John Schussler. A scholar is included among the top collaborators of John Schussler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Schussler. John Schussler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Sierra, Mónica S., Celia E. Coto, Carolina Porras, et al.. (2025). Validation of TypeSeq2, a Next-Generation–Based Sequencing Assay for the Detection of 46 Human Papillomavirus Genotypes, at the US National Cancer Institute and Costa Rica Laboratories. The Journal of Infectious Diseases. 232(6). e906–e915.

2.

Sierra, Mónica S., Peter Dull, Rolando Herrero, et al.. (2025). Human papillomavirus type 16 and 18 viral clearance and progression to precancer among women aged 18–25 years enrolled in the Costa Rica HPV prophylactic vaccine trial (CVT). Vaccine. 50. 126841–126841.

3.

Cortés, Bernal, Carolina Porras, Danping Liu, et al.. (2025). Human papillomavirus (HPV) type 16 and type 18 antibody concentrations after a single dose of bivalent HPV vaccine in girls aged 9–14 years compared with three doses of quadrivalent HPV vaccine in women aged 18–25 years in Costa Rica (PRIMAVERA): a non-randomised, open-label, immunobridging, non-inferiority trial. The Lancet Infectious Diseases. 25(12). 1314–1324.

4.

Kamuyu, Gathoni, Filomeno Coelho da Silva, Vanessa Tenet, et al.. (2024). Global evaluation of lineage-specific human papillomavirus capsid antigenicity using antibodies elicited by natural infection. Nature Communications. 15(1). 1608–1608. 2 indexed citations

5.

Giuliano, Anna R., Birgitta E. Michels, Allan Hildesheim, et al.. (2024). Natural history of HPV-16 E6 serology among cancer-free men in a multicenter longitudinal cohort study. JNCI Journal of the National Cancer Institute. 117(5). 915–923. 2 indexed citations

6.

Herrero, Rolando, John Schussler, Carolina Porras, et al.. (2023). Prevalencia y determinantes de la infección por virus de papiloma humano en mujeres jóvenes de Guanacaste y Puntarenas, Costa Rica, 2004-2005. Salud Pública de México. 65(3, may-jun). 253–264. 1 indexed citations

7.

Sierra, Mónica S., Sabrina H. Tsang, Carolina Porras, et al.. (2022). Analysis of cervical HPV infections among unvaccinated young adult women to inform vaccine strategies in this age group: the Costa Rica HPV Vaccine Trial. Sexually Transmitted Infections. sextrans–2022.

8.

Hu, Shangying, Aimée R. Kreimer, Carolina Porras, et al.. (2022). Performance of Cervical Screening a Decade Following HPV Vaccination: The Costa Rica Vaccine Trial. JNCI Journal of the National Cancer Institute. 114(9). 1253–1261. 3 indexed citations

9.

Tsang, Sabrina H., Partha Basu, Noemi Bender, et al.. (2020). Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines. Vaccine. 38(38). 5997–6006. 15 indexed citations

10.

Kreimer, Aimée R., Rolando Herrero, Joshua N. Sampson, et al.. (2018). Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies. Vaccine. 36(32). 4774–4782. 97 indexed citations

11.

Castle, Philip E., Walter Kinney, Li C. Cheung, et al.. (2017). Why does cervical cancer occur in a state-of-the-art screening program?. Gynecologic Oncology. 146(3). 546–553. 48 indexed citations

12.

Herrero, Rolando, Sholom Wacholder, Ana Cecilia Rodríguez, et al.. (2011). Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica. Cancer Discovery. 1(5). 408–419. 116 indexed citations

13.

Schiffman, Mark, Rolando Herrero, Rob DeSalle, et al.. (2005). The carcinogenicity of human papillomavirus types reflects viral evolution. Virology. 337(1). 76–84. 419 indexed citations

14.

Bratti, M. Concepción, Ana Cecilia Rodríguez, Mark Schiffman, et al.. (2004). Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10 000 women in Guanacaste, Costa Rica Descripción de un estudio prospectivo de siete años sobre la infección por el virus del papiloma humano y el cáncer cervicouterino en 10 000 mujeres de Guanacaste, Costa Rica. SHILAP Revista de lepidopterología. 1 indexed citations

15.

Bratti, M. Concepción, Ana Cecilia Rodríguez, Mark Schiffman, et al.. (2004). Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10 000 women in Guanacaste, Costa Rica. Revista Panamericana de Salud Pública. 15(2). 75–89. 72 indexed citations

16.

Ferreccio, Catterina, M. Concepción Bratti, Mark E. Sherman, et al.. (2003). A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer.. PubMed. 12(9). 815–23. 57 indexed citations

17.

Lörincz, Attila T., Philip E. Castle, Mark E. Sherman, et al.. (2002). Viral load of human papillomavirus and risk of CIN3 or cervical cancer. The Lancet. 360(9328). 228–229. 203 indexed citations

18.

Castle, Philip E., Mark Schiffman, Patti E. Gravitt, et al.. (2002). Comparisons of HPV DNA detection by MY09/11 PCR methods. Journal of Medical Virology. 68(3). 417–423. 151 indexed citations

19.

Schussler, John, et al.. (1977). Zur Frage der Ploidiereduktion bei der Carcinogenese an der Cervix uteri: Numerische Chromosomenanomalien beim Carcinoma in situ. Archives of Gynecology and Obstetrics. 222(4). 285–293. 1 indexed citations

20.

Schussler, John, et al.. (1975). Cytogenetische Untersuchungen an Praecancerosen und Carcinomen der Cervix uteri. Archives of Gynecology and Obstetrics. 220(2). 139–159. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact